In a letter, K.W FItch (Armour) stated that Armour had not preferentially exported plasma stocks out of the USA which had been produced from plasma collected prior to the FDA ruling.
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Regulation of Commercial Factor Concentrates